Print
Email
Print Edition Stories
MHT's Emerging Technologies Forum: Health IT and the Cloud
MHT's Julie Donnelly: Biotechs lag in social media use
Harvard Bioscience Inc. has added to its 20 wholly-owned subsidiaries with its latest acquisition of behavioral measurement products developer Coulbourn Instruments.
Holliston-based Harvard Bioscience (Nasdaq: HBIO) develops, manufactures and markets products and instruments in the life sciences field. The company bought all of Coulbourn’s assets for an undisclosed amount, although Harvard Bioscience CEO Chane Graziano noted in a statement today that the acquisition is expected to add “approximately $4 million in annual revenues.”
Among the brands Harvard Bioscience operates under are Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, KD Scientific, Hugo Sachs Elektronik, Scie-Plas, BTX and Denville Scientific. The company has operations in the U.S., the U.K., Germany, France, Spain and Canada.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
